Decheng Capital is a leading investment firm that provides capital and strategic support to early stage life science companies with revolutionary technologies and growth stage healthcare companies with strong market presence. We are a group of dedicated professionals with complementary expertise who have outstanding track records of building highly successful companies globally. Founded in 2012, Decheng continues to capitalize on a historic opportunity in the rapid growth of healthcare industry as well as breakthroughs in life science research. With over $2 billion in capital under management and support from some of the most prestigious LPs in the world, Decheng is poised to deliver superior returns for our investors and create value for our entrepreneur partners.

Checkmate Pharmaceuticals

Terns Pharmaceuticals

VelosBio

Sema4

Omniome

ReadCoor

Invitae

SentreHEART

Equillium

Aadi Bioscience

Alpine Immune Sciences

Apexigen

Everest Medicines

Arcus Biosciences

ARMO BioSciences

Decheng Capital

Decheng is a technology-driven company that specializes in providing advanced solutions for the global textile industry. With a focus on innovation and sustainability, Decheng offers a range of products and services designed to enhance the efficiency and environmental friendliness of textile manufacturing processes.

Decheng

COM:DECHENG

Decheng

Filings Not Available